Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "genentech"

NewLink stock soars amid deal with Genentech for cancer therap...

NewLink Genetics stock soared on the announcement that it could earn $1 billion through a newly inked deal with Genentech to develop cancer immunotherapies. NewLink's name has been in the news lately because the Iowa company holds the commercial ... San Francisco Chronicle, 3 hours ago
Genentech, NewLink deal could be worth more than $1B Drug Discovery News, 1 day ago
[x]  

17 images for genentech

BenefitNews.com, 22 hours ago
Pharma Letter, 2 days ago
San Francisco Examiner, 2 days ago
OncLive, 4 days ago
Drug Discovery and Development, 2 days ago
Securities Technology Monitor, 2 days ago
bizjournals.com, 2 days ago
bizjournals.com, 2 days ago
Pharma Letter, 6 days ago
Pharma Letter, 1 week ago

NewLink-Roche Ink Deal for Oncology Candidate Development

NewLink Genetics Corporation ( NLNK ) announced that it has signed an exclusive worldwide license agreement with Genentech, a subsidiary of Roche ( RHHBY ), for the development of its oncology candidate NLG919. NLG919, an IDO inhibitor, is in phase ...
 Yahoo! Finance1 day ago NewLink, Genentech ink licensing deal for development of NLG919  Pharmaceutical Business Review1 day ago

NewLink Genetics could get more than $1B from partnership with Roche on potential cancer drug

NEW YORK NewLink said it will get $150 million upfront from Genentech, a unit of Swiss drugmaker Roche, and could receive more than $1 billion in payments based on milestones, as well as royalties if the drug is approved. The drug, now called ...
 FOXBusiness.com2 days ago NewLink Genetics rises on Roche cancer partnership  Yahoo! UK and Ireland2 days ago Genentech pays $150M upfront to partner on NewLink's immuno-oncology drug  FierceBiotech3 days ago NewLink And Roche Sign $1 Billion Licensing Agreement  Bidness Etc2 days ago
[x]  

Genentech's IPF-treating drug Esbriet receives FDA approval

Roche Group subsidiary Genentech has received approval from US Food and Drug Administration (FDA) for Esbriet (pirfenidone) drug to treat patients with idiopathic pulmonary fibrosis (IPF). Esbriet is an oral medicine believed to interfere with the ...
 Pharmaceutical Technology5 days ago Genentech receives FDA approval for idiopathic pulmonary fibrosis drug in US  Individual.com6 days ago Genentech gets FDA approval for Esbriet to treat idiopathic pulmonary fibrosis  Pharmaceutical Business Review6 days ago FDA Approves EsbrietĀ® (pirfenidone) for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) in the United States  Yahoo! UK and Ireland1 week ago
[x]  
Securities Technology Monitor

Roche/Genentech's Herceptin (trastuzumab) HER2-Positive Breast Cancer Treatment Report 2014 - Forecast and Market Analysis to 2023

Research and Markets (http://www.researchandmarkets.com/research/7lgfb3/herceptin) has announced the addition of the "Herceptin (HER2-Positive Breast Cancer) - Forecast and Market Analysis to 2023" report to their offering. Roche/Genentech's ...
 Individual.com3 days ago Research and Markets: Roche/Genentech's Perjeta (HER2-Positive Breast Cancer Treatment) - Forecast and Market Analysis to 2023  TMC Net2 days ago Roche/Genentech's Perjeta (HER2-Positive Breast Cancer Treatment) - Forecast and Market Analysis to 2023  Individual.com3 days ago RESEARCH AND MARKETS : Roche/Genentech's Herceptin (trastuzumab) HER2-Positive Breast Cancer Treatment Report 2014 - Forecast and Market Analysis to 2023  4 Traders3 days ago
[x]  
Pharma Letter

NewLink Genetics out-licenses NLG919 to Genentech20-10-2014

US biotech firm NewLink Genetics (Nasdaq: NLNK) saw its share price rocket 21.2% in morning trading today, after it announced a deal with Genentech on an early-stage cancer program which could earn NewLink more than $1.15 billion. NewLink has ...
 Pharma Letter2 days ago New Link Genetics and Genentech team up in cancer immunotherapy  Seeking Alpha3 days ago NewLink Genetics signs multi-million-dollar contract with Genentech  Des Moines Business Record2 days ago NewLink Scores Major Partners With Roche's Genentech  24/7 Wall St3 days ago
[x]  

Genentech Garners FDA Approval of Esbriet for Idiopathic Pulmonary Fibrosis

Genentech reported that the U.S. Food and Drug Administration has approved Esbriet as a treatment for idiopathic pulmonary fibrosis in the United States. "This is a historic day for the people and their families in the United States who live with ...
 Individual.com3 days ago ROCHE BEARER SHARE : Genentech -2014 AAO Annual Meeting  4 Traders3 days ago ROCHE BEARER SHARE : Genentech Garners FDA Approval of Esbriet for Idiopathic Pulmonary Fibrosis  4 Traders3 days ago

New Findings on Immunoglobulins from Genentech, Inc. Summarized (Real-time immuno-polymerase chain reaction in a 384-well format: Detection of...

 4 Traders11 hours ago

Research Data from Genentech, Inc. Update Understanding of Clinical Trials and Studies (Genetic variability of VEGF pathway genes in six randomized...

Research Data from Genentech, Inc. Update Understanding of Clinical Trials and Studies (Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy) By a News ...
 4 Traders16 hours ago Clinical trials accumulate data for novel anti-VEGF  Orthopedics Today1 day ago
Securities Technology Monitor

Upcoming World Antibody-Drug Conjugate (ADC) Meeting and Awards in San Diego Highlight California's Growing Cancer Therapeutics Hub

Company News: Page (1) of 1 - 10/21/14 print page Genentech, Amgen, Igenica, and 8 Additional California Companies Scheduled to Present (October 21, 2014) SAN DIEGO, Calif. , Oct. 21, 2014 /PRNewswire-iReach/ -- Antibody-drug ...
 Digital Media Net1 day ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less